After many years of success, EvidenceNetwork.ca is no longer in operation. We would like to thank everyone who has contributed to the organization over the past decade including our dedicated researchers, newspaper editors, readers and funders. However, now it is time to move onto new ways of looking at knowledge mobilization and policy. Should you have any questions, please feel free to contact Shannon Sampert at s.sampert@uwinnipeg.ca.

Prescription drug costs hurting Canadians

Health Ministers from across Canada will gather in Banff to discuss issues of common interest and explore opportunities to work together. Pharmacare — a program that would see all prescription drug costs covered through a publicly funded system instead of out-of-pocket — will almost certainly be on the agenda.

How a national drug plan can boost the Canadian economy

Canadians pay among the highest costs per capita among OECD countries for prescription drugs, with one Canadian out of 10 unable to fill their prescriptions because of financial reasons.

Canada slow to respond to prescription opioid crisis

In my first career as a pharmacist, I worked in more than 30 pharmacies across Nova Scotia, filling more than 100,000 prescriptions between 1990 and 1995. Some of these were for strong painkillers called opioids — drugs like morphine and oxycodone, which are chemically and biologically very similar to heroin.

Why can’t we fix health care? Blame self-interest

Almost continuously since the second half of the 1990s, Canadians have pointed to health care as their largest national concern and the issue that should receive the greatest attention from Canada’s leaders. Polls taken over the last decade or so have found that health care is typically the highest priority among voters.

Most medications prescribed to children have not been adequately studied

The development of new therapies has provided our health care system with enormous advances, such as insulin for diabetes, antibiotics for infections or chemotherapy for many cancers. Yet these therapies may also cause potential harm, even death, so the benefits have to be carefully weighed against the risks.

Backgrounder: Pharmaceutical policy in Canada

Pharmaceutical costs have been rising dramatically over the past three decades, both in real terms and as a component of health care spending. In 2012, Canadians spent $947 per capita a year on pharmaceuticals, up from $147 per capita in 1985.